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Abstract
 
Hypoxia is a common cause of cell death and is implicated in many disease processes including
stroke and chronic degenerative disorders. In response to hypoxia, cells express a variety of
genes, which allow adaptation to altered metabolic demands, decreased oxygen demands, and
the removal of irreversibly damaged cells. Using polymerase chain reaction–based suppression
subtractive hybridization to find genes that are differentially expressed in hypoxia, we identified
the BH3-only Bcl-2 family protein Noxa. Noxa is a candidate molecule mediating p53-induced
apoptosis. We show that 
 
Noxa
 
 promoter responds directly to hypoxia via hypoxia-inducible
factor (HIF)-1
 
 
 
. Suppression of Noxa expression by antisense oligonucleotides rescued cells
from hypoxia-induced cell death and decreased infarction volumes in an animal model of
ischemia. Further, we show that reactive oxygen species and resultant cytochrome 
 
c
 
 release
participate in Noxa-mediated hypoxic cell death. Altogether, our results show that Noxa is
induced by HIF-1
 
  
 
and mediates hypoxic cell death.
Key words: Noxa • HIF-1
 
  
 
• hypoxia • apoptosis • ROS
 
Introduction
 
Hypoxia is a well-known cause of cell injury with implications
in many pathologic conditions including cerebral ischemia,
myocardial infarction, and chronic degenerative disorders
(1). In response to hypoxia, cells express a variety of
gene products such as erythropoietin, vascular endothelial
growth factor, glycolytic enzymes, and p27 to satisfy altered
metabolic demands or diminish proliferative rates (2–4).
However, under the extreme hypoxic conditions beyond
the cellular adaptive capability, a number of biochemical
mechanisms involved in necrotic or apoptotic cell death
pathways are activated to remove irreversibly injured cells (2).
To date, transcriptional factor hypoxia-inducible factor 1
 
  
 
(HIF-1
 
 
 
), tumor suppressor p53, and bcl-2 family proteins
are known to play fundamental roles in adaptive or death
process in response to hypoxia (5–7). HIF-1
 
  
 
is induced,
stabilized, and translocated to the nucleus to regulate tran-
scription of a variety of genes involved in the adaptive re-
sponse such as increased O
 
2 
 
delivery and angiogenesis under
situation of oxygen deficiency (8, 9). Although HIF-1
 
 
 
participates largely in adaptive process to hypoxia, paradox-
ically it also mediates hypoxic cell death via the interaction
with p53 or modulation of effector expression (10, 11).
Tumor suppressor gene p53, stabilized by HIF-1
 
 
 
, facili-
tates growth arrest or cell death under hypoxic condition
via (a) its downstream genes such as p21/Waf1/Cip1 and
bax or (b) direct translocation to mitochondria to induce
mitochondrial permeability transition (12–14). Recently, it
has been reported that Bcl-2 family proteins are involved in
cellular hypoxic injury. For example, BNip3, a proapop-
totic BH3-only member of Bcl-2 family proteins, is under
the regulation of HIF-1
 
  
 
and induces apoptotic cell death
(11, 15, 16). However, despite central roles of these mole-
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cules, molecular mechanisms of cell death after hypoxic in-
jury and their downstream effector molecules remain
poorly understood.
We have been attempting to identify novel proapoptotic
genes mediating hypoxic cell death using PCR-based sup-
pression subtractive hybridization. Among the differentially
expressed genes in response to hypoxia we found Noxa.
Noxa is a proapoptotic member of BH3-only Bcl-2 family
proteins and its expression is dependent on p53 through
p53 consensus binding sequence (p53-CBS) on Noxa pro-
moter (17). However, little is known about functions of
Noxa in physiologic status or roles in the process of cell in-
jury. Here we report that Noxa is transcriptionally acti-
vated in hypoxic condition and mediates p53-independent
hypoxic cell death. Its up-regulation of expression in hy-
poxia depends on HIF-1
 
  
 
via hypoxia-responsive element
(HRE) on Noxa promoter. In addition, we show that
Noxa mediates hypoxic cell death by generation of reactive
oxygen species (ROS). Inhibition of endogenous Noxa ex-
pression by antisense (AS) oligonucleotide suppressed cell
death and reduced infarction volumes induced by hypoxia
in ischemic animal model. Based on our results, we pro-
pose that Noxa is another member of BH3-only Bcl-2
family proteins that responds to hypoxia and mediates hy-
poxic cellular injury.
 
Materials and Methods
 
Cell Culture, Hypoxia Condition, Caspase-3 Assay, and Cell
Death Analysis.
 
SK-N-MC, Saos-2, and H719 cells were cul-
tured in RPMI 1640 medium under 5% CO
 
2
 
. For hypoxic condi-
tion, cells in degassed serum- and glucose-deficient medium were
transferred to a hypoxic chamber with 0.5% O
 
2
 
/5% CO
 
2
 
/94.5%
N
 
2
 
. Caspase-3 activity was measured using the Colorimetric Cas-
pase-3 Assay Kit (Calbiochem) according to the manufacturer’s in-
structions. Apoptotic cells, exhibiting altered nuclear morphology
after DAPI staining, were enumerated manually as previously de-
scribed (18) or counted using trypan blue exclusion method.
 
Subtractive Hybridization.
 
Subtractive hybridization was per-
formed with a PCR-Select cDNA Subtraction Kit (CLONTECH
Laboratories, Inc.) according to the manufacturer’s protocol. In
brief, subtractive cDNA library was prepared with poly(A)
 
 
 
RNAs purified from SK-N-MC cells incubated under normoxic
(20% O
 
2
 
; driver) and hypoxic (0.5% O
 
2
 
; tester) conditions for 3 h.
The tester cDNAs were digested with RsaI and linked with adap-
tor oligonucleotides. The tester cDNA was hybridized with an ex-
cess of driver cDNA digested with RsaI (the first hybridization)
and subtracted single-stranded cDNA was converted to double-
stranded DNA by the second hybridization with another adaptor-
linked first hybridization. The subtracted cDNA was amplified by
PCR with the primer set located in adapters and inserted into TA
vector (CLONTECH Laboratories, Inc.).
 
Plasmid Construction and Transient Transfection.
 
DNA encod-
ing human Noxa, p53, or HIF-1
 
  
 
was amplified by PCR from
human kidney cDNA library (CLONTECH Laboratories, Inc.)
and subcloned into the pcDNA3.1 or TA vector tagged with
myc/V5 (Invitrogen). Cells were transfected with expression
plasmid using Transfast Reagent (Promega).
 
Luciferase Assay.
 
The luciferase plasmid used was pGL2
(Promega). Four fragments of the Noxa promoter sequence were
amplified by PCR from human kidney genomic DNA using the
KpnI site–containing upstream primer, F1 (5
 
 
 
-GGTACCTTGA
GACAGAGTCTTATT-3
 
 
 
), F2 (5
 
 
 
-GGTACCGACGGGGT-
TTCACCATATT-3
 
 
 
), F3 (5
 
 
 
-GGTACCTTTCTGCACCCG-
TAAAGTAG-3
 
 
 
), and F4 (5
 
 
 
-GGTACCCCACTCCCAGC-
TCCCGC-3
 
 
 
) primers, respectively, together with a single
downstream primer R1 (5
 
 
 
-AAGCTTTCAGCTACAGAGC-
CCGGG-3
 
 
 
) containing HindIII site. Each Noxa promoter frag-
ment was digested with both KpnI and HindIII and it was in-
frame cloned into pGL2 luciferase reporter vector to generate
pGL2-Noxa-1, pGL2-Noxa-2, pGL2-Noxa-3, and pGL2-Noxa-4,
in order. For pGL2-Noxa-5 construct, a 256-bp fragment rang-
ing from 
 
 
 
1,120 to 
 
 
 
1,375 was amplified by PCR using sense
(SE; 5
 
 
 
-GGTACCGACGGGGTTTCACCATATT-3
 
 
 
) and AS
(5
 
 
 
-ACTGAGGTTTGTAGAAAATT-3
 
 
 
) primers and intro-
duced into KpnI and HindIII site of pGL2Basic. Mutant form of
pGL2-Noxa-5 was constructed by changing core sequence of
HRE (CGTG) to GCAC using splicing overlap extension
method (19). Expression vector carrying HIF-1
 
  
 
was cotrans-
fected with luciferase reporter constructs into p53-deleted Saos-2
cells by calcium phosphate precipitation method. Luciferase ac-
tivity was measured on samples containing equivalent amounts of
protein using luminometer and luciferase assay reagents
(Promega).
 
Electrophoretic Mobility Shift Assay (EMSA) and Supershift Analy-
sis.
 
EMSA was performed on nuclear extracts from Saos-2 cells.
The extract preparation and binding reaction were performed as
previously described (20). The double-stranded oligonucleotides
used included (a) commercially available consensus HIF-1
 
  
 
gel
shift oligonucleotide 5
 
 
 
-TCTGTACGTGACCACACTCAC-
CTC-3
 
  
 
(Santa Cruz Biotechnology, Inc.) for positive control,
(b) putative HIF-1
 
  
 
binding site of Noxa promoter 5
 
 
 
-ATTA-
CAGGCGTGAGCCACCGCGT-3
 
 
 
, and (c) mutant Noxa
oligonucleotide 5
 
 
 
-ATTACAGGGCACAGCCACCGCGT-3
 
 
 
.
For supershift analysis, 1 
 
 
 
g monoclonal antibody against HIF-1
 
 
 
(Santa Cruz Biotechnology, Inc.) or isotype control antibody
(Sigma-Aldrich) was added to the reaction mixture before the ad-
dition of labeled oligonucleotides. For the binding competition
experiments, unlabeled oligonucleotides were added to the reac-
tion mixture in 100-fold excess.
 
Semiquantitative RT-PCR Analysis.
 
1 
 
 
 
g total RNA extracted
from normoxia- or hypoxia-stimulated cells was converted to
cDNA. The RT-PCR exponential phase was determined on 20–
32 cycles to allow semiquantitative comparisons. PCR regimen
for Noxa involved 94
 
 
 
C, 5 min initial denaturation step, followed
by 32 cycles at 94
 
 
 
C for 30 s, 58
 
 
 
C for 45 s, and 72
 
 
 
C for 45 s on
a Gene Amp PCR system 9700 (PerkinElmer). The resulting
PCR products were separated in 2% agarose gels and visualized
by ethidium bromide staining. For semiquantitative evaluation,
densitometric analysis (Bio-Rad Laboratories) was performed.
 
AS Oligonucleotide.
 
To inhibit expression of endogenous
Noxa, SE (5
 
 
 
-GCCGCCGTGGCCGCCTCTAC-3
 
 
 
) and AS
(5
 
 
 
-CATCTCCGCCGGTGCCGCCG-3
 
 
 
) oligonucleotides were
delivered by streptolysin-O (SL-O) technique as previously de-
scribed (21). In brief, after washing in serum-free RPMI me-
dium, 10
 
6 
 
cells were exposed to dithiothreitol-activated SL-O at
20 
 
 
 
mol/liter SE or AS oligonucleotide in serum-free RPMI.
After incubation of 10 min at 37
 
 
 
C, complete medium was used
to reseal the cells.
 
Immunocytochemistry.
 
Saos-2 cells were fixed with 4% parafor-
maldehyde in PBS and permeabilized with 0.1% Triton X-100.
After blocking with 3% BSA in PBS, the cells were incubated
with anti-Noxa (Zymed Laboratories) or anti–cytochrome 
 
c
 
 (BD 
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Biosciences) antibody for 2 h at room temperature. These anti-
bodies were stained with secondary antibody conjugated with
FITC or Texas Red and viewed using a Nikon E800 microscope
equipped with a cooled CCD camera.
 
Cell Fractionation and Immunoblot Analysis.
 
The harvested cells
were washed and suspended in hypotonic solution (10 mM
HBSS, 10 mM MgCl
 
2
 
, 42 mM KCl) for 5 min on ice, passed
through a 30-gauge needle, and centrifuged at 800 
 
g
 
 for 10 min at
4
 
 
 
C. The supernatants were centrifuged at 150,000 
 
g
 
 for 1 h. The
mitochondrial fraction (pellet) and cytosolic fraction (supernatant)
were collected separately. The proteins were separated using 15%
SDS-polyacrylamide gels and transferred to nitrocellulose mem-
brane. The blots were incubated with anti-Noxa or anti–cyto-
chrome 
 
c
 
 antibody followed by enhanced chemiluminescence–
based detection (Amersham Biosciences). Densitometric analysis
(Bio-Rad Laboratories) was performed for quantitative evalua-
tion.
 
Focal Cerebral Ischemia in Rat.
 
Reversible focal cerebral isch-
emia was performed in male Wistar rats weighing 300–350 g by
occluding middle cerebral artery for 2 h as previously described
(22). After reperfusion, rats were killed at indicated time points by
halothane overdose. Brains were removed, cut into eight coronal
slices, and stained with triphenyl tetrazolium chloride. Infarct vol-
ume was calculated after measuring the infarct areas on coronal
brain sections as previously described (23). Noxa AS (5
 
 
 
-CATGT-
TGTTATCCTCCAG-3
 
 
 
) and SE (5
 
 
 
-GACCTCCTATTGT-
TGTAC-3
 
 
 
) oligonucleotides (2 
 
 
 
g in 1 
 
 
 
l) were injected into
the right lateral ventricle 4 h before the onset of ischemia.
 
In Situ Hybridization.
 
cRNA probes (SE or AS) were pre-
pared by in vitro transcription using T7 or SP6 polymerase from
the coding region of rat Noxa cDNA (sequence data are available
from GenBank/EMBL/DDBJ under accession no. XM_225860)
subcloned into pGEM-T vector (Promega). The probes were la-
beled with FITC and in situ hybridization reactions were per-
formed according to the manufacturer’s instructions (InnoGenex)
using Fast Red as chromogens.
 
Terminal Deoxynucleotidyl Transferase-mediated dUTP Digoxigenin
Nick End Labeling (TUNEL) Assay and Immunohistochemistry.
 
Coronal slices of rat brain were fixed in 10% buffered neutral for-
malin. 5-
 
 
 
m thick tissue sections were analyzed immunohis-
tochemically using anti-Noxa antibody and ABC kit (Vector
Laboratories). TUNEL staining was performed on paraffin-embed-
ded tissue sections using In Situ Cell Death Detection Kit
(Roche) according to the manufacturer’s protocol.
 
Statistical Analysis.
 
All data were presented as mean 
 
  
 
SD
from three or more independent experiments. Statistical compar-
ison between different treatments was performed by Student’s 
 
t
 
test. Differences with P value 
 
 
 
0.05 were considered statistically
significant.
 
Results
 
Hypoxia Induces Noxa mRNA and Protein Expressions.
 
Subtractive hybridization was performed to identify proap-
optotic genes induced by hypoxia in SK-N-MC neuroblas-
toma cells. Among the putative 25 hypoxia-regulated genes
detected by subtractive hybridization, we have focused on
the Noxa gene. Noxa, initially cloned as a PMA-responsive
immediate early gene from acute T cell leukemia (24), is a
proapoptotic member of BH3-only Bcl-2 family proteins
and known to be a candidate mediator of p53-induced
apoptosis (17). To confirm the results of subtractive hybrid-
 
ization, RT-PCR analysis was performed using mRNA
extracted from hypoxia-exposed SK-N-MC neuroblas-
toma cells. An increase of Noxa transcripts was initially
found at 1 h of hypoxia with pronounced induction up to
sixfold around 6 h of stimulation (Fig. 1 A). A statistically
significant increase of Noxa transcripts (Fig. 1 A, 
 
*
 
, P 
 
 
 
0.05) was seen from 4 h of hypoxia (Fig. 1 A). A represen-
tative RT-PCR result was shown in Fig. 1 B. At protein
levels, a significant increase (Fig. 1 B, 
 
*
 
, P 
 
  
 
0.05) was seen
from 2 h of hypoxia with maximal induction around 12 h
after hypoxic insult (Fig. 1 C). A representative blot was
presented in Fig. 1 D. Up-regulation of Noxa transcription
in hypoxia was seen in a variety of human and mouse cells
including endothelial cells, neurons, kidney cells, neuro-
blastomas, leukemias, and breast cancers (unpublished data),
indicating that our findings were not cell type specific.
 
Noxa Up-regulation in Response to Hypoxia Is Independent of
p53.
 
A previous report showed that genotoxic stress such
as DNA damage or infrared exposure induced p53-depen-
dent Noxa transcription via p53-CBS on Noxa promoter
(17). Therefore, we wished to address whether hypoxia-
induced Noxa up-regulation was mediated by p53. p53-
deleted Saos-2 cells or H719 cells with wild-type p53 were
exposed to hypoxia or DNA-damaging agent etoposide for
each indicated time point and expression levels of Noxa and
p21 were determined. p21 is known to be consistently up-
regulated by p53 in response to DNA damage. Consistent
with previous reports, genotoxic stress transcriptionally up-
Figure 1. Hypoxia induces transcriptional and translational up-regulation
of Noxa. SK-N-MC neuroblastoma cells in serum- and glucose-deficient
medium were subjected to hypoxic condition (0.5% O2) for the indicated
times. (A) cDNA was synthesized from the total RNAs extracted from
SK-N-MC cells exposed to hypoxia and subjected to RT-PCR analysis.
32 and 26 cycles of amplification were performed for Noxa and GAPDH,
respectively. Fold increases of Noxa expression (mean   SD) were presented
using densitometry. Noxa expression level at 0 h was arbitrarily defined as
1. *, a statistically significant difference in Noxa expression levels (P   0.05 in
A and C). (B) A representative RT-PCR result. (C) 30  g cell lysates
extracted from hypoxia-exposed cells were subjected to Western blot
analysis using polyclonal anti-Noxa and  -tubulin antibodies. Fold increases
of Noxa protein expression was presented. Noxa expression level at 0 h
was arbitrarily defined as 1. (D) Representative Western blot.Noxa Mediates Hypoxic Injury 116
regulated p53, p21, and Noxa mRNA in H719 cells with
wild-type p53 (Fig. 2, A and B). In p53-deleted Saos-2
cells, etoposide failed to induce both Noxa and p21 expres-
sion (Fig. 2, A and B), suggesting that Noxa and p21 tran-
scriptional up-regulations depend on p53 status in response
to genotoxic stress. In contrast, Noxa mRNA, but not p21,
was up-regulated in both H719 and Saos-2 cells by hypoxic
stress (Fig. 2 A, right). In protein levels, Noxa expression by
hypoxia was in line with mRNA (Fig. 2, C and D). To-
gether, these results suggest that Noxa transcription and
translation are regulated regardless of p53 status in response
to hypoxia. To reinforce our results on the roles of hypoxia
and p53 in Noxa transactivation machinery, we introduced
wild-type p53 into Saos-2 cells. After 24 h of transfection,
cells were exposed to hypoxia or treated with etoposide for
8 h and then Noxa expression levels were determined. Sig-
nificant up-regulation of Noxa expression was seen in un-
treated or etoposide-treated Saos-2 cells with wild-type
p53 as compared with mock-transfected cells (Fig. 2, E and
F). Hypoxic exposure of Saos-2 cells transfected with wild-
type p53 did not increase Noxa expression level signifi-
cantly as compared with mock-transfected cells (Fig. 2, E
and F). These results further support that Noxa transactiva-
tion machinery responds to hypoxia in a p53-independent
manner.
Noxa Promoter Responds to Hypoxia via HIF-1 . Previ-
ous results led us to determine the promoter region of
Noxa that responds to hypoxia. Promoter assay was per-
formed using luciferase reporter gene linked to upstream
region from initiation codon ATG of Noxa, as shown in
Fig. 3 A. Luciferase activities were increased to 4.8-fold
and 5.2-fold in pGL2-Noxa-1 and pGL2-Noxa-2 as com-
pared with pGL2Basic, respectively. No significant increase
of luciferase activity was observed when transfected with
pGL2-Noxa-3 and pGL2-Noxa-4 (Fig. 3 B). This result
suggests that the hypoxia-responsive region of Noxa pro-
moter is located at  1,375 to  1,120 bp from the initia-
tion codon ATG. To confirm our results, we inserted this
256-bp fragment into pGL2Basic to construct pGL2-
Noxa-5 and performed promoter assay. Luciferase activity
of pGL2-Noxa-5 was increased to 5.7-fold, confirming
that this 256-bp fragment of Noxa promoter responds to
hypoxia (Fig. 3 B). HIF-1  is known to be a major tran-
scription regulator in hypoxic condition. Thus, to deter-
mine whether the hypoxic up-regulation of Noxa mRNA
was driven by HIF-1 , we cotransfected Saos-2 cells with
luciferase reporter plasmid and pcDNA-HIF-1 . As shown
in Fig. 4 A, luciferase activities of pGL2-Noxa-1, pGL2-
Noxa-2, and pGL2-Noxa-5 were increased to fivefold, in-
dicating that Noxa responded to hypoxia via HIF-1 .
Figure 2. Noxa is transcriptionally up-regulated
by hypoxia in a p53-independent manner.
H719 cells with wild-type p53 and p53-deleted
Saos-2 cells were incubated with 10  M etopo-
side or cultured under 0.5% O2 in serum- and
glucose-deficient medium for the indicated times.
(A) RT-PCR analysis. cDNA synthesized from
total RNAs extracted from etoposide-treated
or hypoxia-exposed cells were subjected to
RT-PCR analysis for p53, p21, and Noxa.
Quantitations of expression levels were
achieved after adjustment for the expression
levels of the housekeeping gene, GAPDH. The
cycle numbers for amplification were 30 for
p53, 32 for p21 and Noxa, and 26 for GAPDH.
(B) Determination of relative Noxa mRNA
expression was achieved by densitometric analysis
(*, P   0.05). Noxa expression level of normoxic
cells was defined as 1. C, untreated normoxic;
E, etoposide; H, hypoxia. (C) 30  g cell lysates
extracted from etoposide-treated or hypoxia-
exposed cells were subjected to Western blot
analysis using anti-p53, anti-p21, anti-Noxa,
and  -tubulin antibodies. (D) Determination of
relative Noxa protein expression was achieved
by densitometric analysis (*, P   0.05). Noxa
expression level of normoxic cells was defined
as 1. (E) Saos-2 cells were transiently transfected
with 1  g pcDNA-p53. After 24 h, cells were
untreated or treated with etoposide or hypoxia
for 8 h. Cell lysates were subjected to Western
blot analysis using anti-p53 or anti-Noxa anti-
body. p53 TF, p53 transfection. (F) Determina-
tion of relative Noxa protein expression was
achieved by densitometric analysis (*, P  
0.05). Noxa expression level of untreated nor-
moxic cells with mock transfection was defined
arbitrarily as 1.Kim et al. 117
Next, we analyzed the HRE consensus motif proposed by
Wenger and Gassmann (25): (T, G, C) (A, G) CGTG (C,
G, A) (G, T, C) (G, T, C) (G, T, C). In this 256-bp frag-
ment, no more than a single base mismatch outside the
CGTG core sequence was allowed. We found a single
HRE motif fitting Wenger’s and Gassmann’s consensus se-
quence located at  1,275 bp upstream of the translation
start codon. We constructed a site-directed mutant plasmid
of HRE motif (pGL2-Noxa-M5), changing from 5 -
GGCGTG-3   to 5 -GGGCAC-3 . pGL2-Noxa-M5, an
HRE mutant form of pGL2-Noxa-5, lost luciferase activity
(Fig. 4 B). Our data demonstrate that Noxa promoter re-
sponds to HIF-1   through the HRE motif located at
 1,275 from the ATG start codon. To prove direct in-
volvement of HIF-1  in the regulation of Noxa transcrip-
tion, we performed EMSA with an oligonucleotide con-
taining the extended HRE consensus sequence derived
from the human Noxa promoter (nucleotides from  1,290
to  1,268). A known consensus HIF-1  binding oligonu-
cleotide and mutated core HRE sequence were used for
Figure 3. Activation of Noxa promoter by hypoxia. (A) The Noxa
promoter and various luciferase reporter constructs. HRE sites (closed
circle) and p53-CBS (closed box) were shown. Numbering refers to the
region of the Noxa promoter inserted into the parental pGL2Basic vector
relative to the ATG translation initiation site as  1. (B) Saos-2 cells were
transiently transfected with 1  g indicated luciferase reporter plasmid.
After 24 h of transfection, the cells were subjected to hypoxia for 6 h and
then luciferase activity was determined. For each construct tested, fold
increases of luciferase activities with hypoxia versus luciferase activity in
normoxia (arbitrarily defined as 1) were presented. The mean   SD of
three independent experiments is shown.
Figure 4. Noxa promoter responds to hypoxia via HIF-1 . (A) Saos-2
cells were transiently cotransfected with 1  g indicated luciferase report
plasmid and pcDNA-HIF-1  or mock vector, and then cultured in nor-
moxia. After 24 h of cotransfection, luciferase activities were determined.
The values represent the average luciferase activity of three independent
experiments. The bars indicate standard error. (B) Luciferase reporter
plasmid containing a 256-bp fragment with one putative HRE of Noxa
promoter, starting from  1,120 bp of ATG initiation codon, was con-
structed (pGL2-Noxa-5). Mutant form of pGL2-Noxa-5 was constructed
by changing the core sequence of HRE (CGTG) to GCAC. Saos-2 cells
were transiently transfected with the indicated luciferase reporter plasmid
and exposed to hypoxia for 6 h, or cotransfected with pcDNA-HIF-1 .
Luciferase activities were determined as described above. The mean  
SD of three independent experiments is shown. (C) EMSA and supershift
analysis of human Noxa. Lane 1, 32P-Noxa oligonucleotide; lane 2,
32P-Noxa oligonucleotide and nuclear extracts from Saos-2 cells cultured
in normoxia (NN); lane 3, 32P-consensus oligonucleotide and nuclear
extracts from Saos-2 cells cultured in hypoxia (NH); lane 4, 32P-Noxa
oligonucleotide and NH; lane 5, 32P-Noxa oligonucleotide and 100-fold
excess of unlabeled cold Noxa oligonucleotide with NH; lane 6, 32P-
Noxa oligonucleotide and anti–HIF-1  antibody with NH; lane 7, 32P-
Noxa oligonucleotide and isotype control antibody with NH; lane 8,
32P mutant oligonucleotide and NH.Noxa Mediates Hypoxic Injury 118
positive and negative control, respectively. As evident from
Fig. 4 C, the addition of 32P-labeled Noxa promoter oligo-
nucleotide to nuclear protein extracts from Saos-2 cells cul-
tured under hypoxic condition resulted in complex forma-
tion (Fig. 4 C, lane 3). The specificity of this complex was
confirmed by competitive inhibition with an excess of the
same unlabeled cold oligonucleotide (Fig. 4 C, lane 5) and
a supershift analysis using anti–HIF-1 . The addition of
anti–HIF-1  antibody to binding reaction mixture resulted
in the supershift of complex (Fig. 4 C, lane 6), whereas
control anti-Flag antibody did not influence the mobility of
complex (Fig. 4 C, lane 7). Taken together, our data
clearly show that hypoxic regulation of human Noxa is
mediated by HIF-1 .
Suppression of Endogenous Noxa Expression Protects against
Hypoxic Cell Death. To assess the role of Noxa in cell
death after hypoxic assaults, we performed transfection and
suppression assays in Saos-2 cells. Cells were transiently
transfected with pcDNA-Noxa or mock vector and after
24 h of transfection cells were subjected to hypoxic or nor-
moxic condition. Cell death rates were determined using
trypan blue exclusion method at the indicated time points.
As presented in Fig. 5 A, Noxa-transfected cells with hy-
poxic exposure showed significantly higher cell death rates
compared with Noxa-transfected normoxia-cultured or
mock-transfected hypoxia-exposed cells (Fig. 5 A, *, P  
0.05), suggesting that Noxa might sensitize the cells to hy-
poxic injury. To further characterize the roles of Noxa in
hypoxic injury, we synthesized SE and AS oligonucleotides
corresponding to Noxa coding sequences. Using AS and
SE, we examined whether inhibition of endogenous Noxa
expression with AS might affect the extent of cell death af-
ter hypoxia. Cell death analysis showed that suppression of
Noxa expression by AS rescued the cells from hypoxic in-
jury as opposed to SE (Fig. 5 B, *, P   0.05). Time-depen-
dent attenuations of Noxa expression by SL-O–delivered
AS are presented in Fig. 5 C. Taken together, our results
indicated that Noxa mediated hypoxia-induced cell death.
Noxa Facilitates Cell Death by Generation of ROS. ROS
plays a central role in the arena of cell injuries in response
to hypoxia by perturbation of mitochondria, e.g., perme-
ability transition or membrane peroxidation. It has been
known that Noxa, targeting to mitochondria, induces loss
of mitochondrial membrane potential (  m; reference 17).
In addition, mitochondria are the major organelle respon-
sible for intracellular ROS generation. Therefore, we hy-
pothesized that Noxa might mediate hypoxic cell death by
production of ROS. To examine the possibility that Noxa
may perturb mitochondria by ROS generation, we tran-
siently transfected Saos-2 cells with pcDNA-Noxa and
determined the changes of ROS level using ROS-sensi-
tive fluorescent dye, 2 , 7 -dichlorofluorescein diacetate
(DCF-DA). As presented in Fig. 6 A, an increase in the
ROS level was observed in Noxa-transfected cells in com-
parison with mock-transfected cells. Next, we analyzed
the suppression effects of endogenous Noxa on ROS pro-
duction in hypoxia. Cells whose endogenous Noxa ex-
pression was blocked with AS were cultured in hypoxic
condition for 3 h followed by 1 h of reoxygenation. Cells
were then sequentially stained with DCF-DA and propid-
ium iodide (PI) followed by FACS® analysis. The popula-
tions of living cells, as indicated by their ability to exclude
PI, were analyzed to discard the possibility that ROS were
byproducts of cell death. As shown in Fig. 6 B, AS sup-
pressed ROS generation induced by hypoxia, whereas SE
failed to reduce ROS levels. Further, to establish that
ROS contributed directly to Noxa-mediated hypoxic cell
death, cells were transiently transfected with 1  g
pcDNA-Noxa in the presence or absence of antioxidant
N-acetylcysteine (NAC). NAC reduced the ROS level
and protected cell death in pcDNA-Noxa–transfected cells
in a concentration-dependent manner (Fig. 6 C). Our re-
sults showed that ROS generation was crucial in Noxa-
triggered cell death.
Figure 5. Noxa mediates cell death in response to hypoxia. (A) Saos-2
cells were transiently transfected with 1  g pcDNA-Noxa or mock vector.
After 18 h of transfection, cells were cultured in normoxic condition or
subjected to hypoxia for the indicated time points. Dead cells were
counted by trypan blue exclusion method (*, P   0.05). (B) Saos-2 cells
were treated with AS or SE oligonucleotides 6 h before hypoxic assault
and then subjected to hypoxia for the indicated times. Dead cells were
counted by the trypan blue exclusion test. The mean   SD of three inde-
pendent experiments is shown (*, P   0.05). (C) Representative Western
blot for Noxa after treatment with AS or SE.Kim et al. 119
Noxa Induces ROS-dependent Cytochrome c Release and
Caspase Activation in Hypoxia. We have demonstrated that
Noxa mediated hypoxic cell death via generation of ROS.
Previous characterization of Noxa indicated that Noxa was
a member of BH3-only mitochondrial proteins that dissi-
pated mitochondrial membrane potential with resultant cy-
tochrome  c release (17). Thus, we wished to address
whether ROS induced by Noxa mediated cytochrome c re-
lease. Saos-2 cells were transiently transfected with pcDNA-
Noxa or mock vector. ROS increase and cytochrome c re-
lease were sequentially determined from 8 h of transfection.
As shown in Fig. 7 A, ROS increases were well correlated
with cytochrome c releases. In agreement with cytochrome
c release, caspase-3 activities were increased up to ninefold
after 16 h of transfection (Fig. 7 B). To reinforce our results,
Noxa- or mock-transfected cells were incubated with or
without 10 mM NAC for an additional 6 h. Cells with cy-
tochrome c release were enumerated manually based on im-
munocytochemistry staining or were determined by West-
ern blots after cell fractionation (Fig. 7 C). In addition,
cytochrome  c release was suppressed in NAC-incubated
cells (Fig. 7 C), suggesting that generation of ROS was re-
sponsible for cytochrome c release in Noxa-mediated cell
death. Next, the cells treated with AS were subjected to hy-
poxic incubation and the number of cells with cytochrome c
release was compared with that of SE-treated cells. As
shown in Fig. 7 D, cytochrome c release was detected in
 1, 2, 5, 7, and 9% of AS-treated cells in comparison with
2, 7, 27, 36, and 49% of SE-treated cells at the indicated
time points. Attenuation of cytochrome c release by Noxa
AS is shown in Fig. 7 D, right. Taken together, our data in-
dicate that Noxa induced ROS-dependent cytochrome c
release and caspase-3 activation.
Noxa Level Increases after Transient Ischemia in Rat Brain
Middle Cerebral Artery Occlusion (MCAO) Model. To ad-
dress whether Noxa mRNA and protein expressions were
enhanced in in vivo brain ischemia/hypoxia, we performed
in situ hybridization using cRNA probe and immunohis-
tochemistry in serial coronal sections derived from the rat
transient MCAO model. After transient MCAO for 2 h,
rats were killed from 6 h of MCA occlusion with a 1-h in-
terval and their brains were removed. Enhanced Noxa
mRNA and protein expressions were detected in peri-
ischemic areas (penumbra) of the ipsilateral (infarcted)
hemisphere from 4 h of infarction, peaking at 12 h after
ischemia (Fig. 8, A–D). TUNEL assay performed in brain
slices adjacent to those used for analysis of Noxa expression
revealed apoptotic nuclei in the ipsilateral hemisphere from
14 h of ischemia as compared with the contralateral hemi-
sphere (Fig. 8, E and F).
Liposomal Delivery of Noxa AS Oligonucleotide Reduces
Acute Cerebral Infarction. To determine whether suppres-
sion of Noxa expression may affect the extent of cerebral
ischemia in vivo, AS in cationic liposomes was adminis-
tered into the right lateral ventricle of rats 4 h before
MCAO. The rats were killed after 16 h of MCA occlusion
and their brains were removed for evaluation of infarction
volume. There was a significant decrease in infarct volume
in rats given the Noxa AS compared with SE (Fig. 9, A and
C). Attenuations of Noxa expressions according to slice
levels were observed in Western blot analysis (Fig. 9 B).
The infarction volume of the control animal (SE) was
Figure 6. ROS mediates Noxa-induced
hypoxic cell death. (A) Saos-2 cells were tran-
siently transfected with 1  g pcDNA-Noxa or
mock vector. After 16 h of transfection, cells
were stained with DCF-DA and subjected to
flow cytometric analysis. (B) The cells were
untreated or treated with 20  mol/liter SE or
AS oligonucleotides before 4 h of hypoxic expo-
sure, subjected to hypoxia for 3 h, and followed
by reoxygenation for 1 h. The cells were double
stained with PI and DCF-DA and analyzed by
flow cytometry using CELLQuest™ software.
(C) Saos-2 cells were transiently transfected
with 1  g pcDNA-Noxa or mock vector. After
16 h of transfection, cells were treated with or
without NAC for an additional 12 h and cell
death assay was performed using the trypan blue
exclusion test.Noxa Mediates Hypoxic Injury 120
an HIF-1 –dependent hypoxia-inducible gene and medi-
ates hypoxic cell death in an ROS-dependent manner.
Our initial experiments by subtraction hybridization,
RT-PCR, and Western analysis strongly suggest that hy-
poxia up-regulates Noxa expression. Noxa, initially identi-
fied as a PMA-responsive gene in leukemia cells (24), is
known to be a downstream effector molecule of tumor
suppressor p53 because genotoxic stress such as DNA dam-
age or X rays induced Noxa up-regulation through p53-
CBS on Noxa promoter (17). Consistent with this finding,
p53 and its downstream effectors, p21 and Noxa, were up-
regulated by genotoxic agent etoposide in H719 cells with
wild-type p53, but not in p53-deleted Saos-2 cells. This re-
sult indicates that genotoxic stress up-regulated Noxa ex-
pression via p53-dependent pathways. However, we can-
not completely discard the possibility that additional
molecules or pathways other than p53 might be involved in
the transactivation pathway of Noxa expression by geno-
toxic stress. Interestingly, Noxa, but not p21, was transcrip-
tionally and translationally up-regulated by hypoxic stress
in p53-deleted Saos-2 cells. In addition, hypoxic stress on
Figure 7. Noxa induces ROS-dependent
cytochrome  c release in response to hypoxia.
(A) Saos-2 cells were transiently transfected
with 1  g pcDNA-Noxa and change of ROS
levels was sequentially determined at the indi-
cated time point by flow cytometric analysis
(left). Cytochrome c releases at the correspond-
ing time points were determined by Western
blot after cell fractionation (right). Mt., mito-
chondria; Cyt., cytoplasm. (B) Saos-2 cells were
transiently transfected with 1  g pcDNA-Noxa
or mock and then caspase-3 activity was deter-
mined at the indicated time point. Caspase-3
activity of mock-transfected cells after 8 h of
transfection was arbitrarily defined as 1. (C) Saos-2
cells were transiently transfected with 1  g
pcDNA-Noxa or mock vector. After 16 h of
transfection, cells were treated with or without
10 mM NAC for an additional 8 h and cyto-
chrome c release was determined by immuno-
cytochemistry using anti–cytochrome c antibody.
Percentage of cell numbers of three independent
experiments with standard errors is presented
(left). Representative Western blot for cyto-
chrome  c release after cell fractionation was
presented (right). (D) Cells were treated with
SE or AS oligonucleotides for 4 h, exposed to
hypoxia for 3 h, and reoxygenated for an addi-
tional hour. Numbers of cells with released
cytochrome c were counted at indicated time
points (time was counted after 1 h of reoxygen-
ation) and average percentages with standard
errors are presented (left). Representative Western
blot for cytochrome c after treatment with AS or
SE is shown (right).
154.24   28.38 mm3, whereas that of the experimental
group (AS) was reduced to 48.86   13.46 mm3 (Fig. 9 C,
*, P   0.05).
Discussion
Hypoxia/ischemia is important in human pathophysiol-
ogy because it participates in numerous pathological pro-
cesses such as ischemic stroke, myocardial infarction, and
chronic degenerative disorders. When exposed to hypoxia,
cells transactivate a variety of gene products to adapt to al-
tered metabolic status or to remove irreversibly damaged
cells (2). Among the transcriptional factors responding to
hypoxia, HIF-1  and p53 appear to be key modulators be-
cause they transactivate numerous genes responsible for in-
creased oxygen delivery, cell cycle arrest, or apoptosis (25–
28). Although survival genes and their molecular pathways
that protect against cell death in response to hypoxia are
rather well documented, death-promoting genes induced
by hypoxia are less clarified. Here we have demonstrated
that Noxa, a member of BH3-only Bcl-2 family proteins, isKim et al. 121
Saos-2 cells with reintroduced p53 did not induce a signifi-
cant additional increase of Noxa expression. Dissociation of
transactivation property of p53 between genotoxic damage
and hypoxia may explain the reasons why restoration of
p53 had no additive effect on the induction of Noxa in hy-
poxia. A previous report showed that hypoxia induced p53
accumulation, but in contrast to DNA damage, hypoxia
failed to induce endogenous downstream p53 effector
mRNA and proteins (29). Whatever mechanisms are in-
volved in p53-dependent transactivation pathways, our
data suggest that Noxa expression is regulated regardless of
p53 status in response to hypoxia. These results prompted
us to perform Noxa promoter assay.
The data obtained from luciferase reporter assay, mutant
plasmid, and EMSA clearly showed that Noxa expression
was regulated in a p53-independent manner. HIF-1  is a
master regulator of oxygen homeostasis (9). As a whole,
HIF-1   functions as a survival factor because its target
genes participate in increasing oxygen delivery or reducing
metabolic demands (30–32). However, HIF-1  serves as a
pro-death gene depending on the severity of hypoxic stim-
ulus (1, 27). To date, it seems that proapoptotic activity of
HIF-1  is driven from interaction with p53 or modulation
of proapoptotic Bcl-2 family protein (33, 34). Our data
demonstrated that Noxa is a first member of a proapoptotic
gene regulated directly by both HIF-1  and p53, thus link-
ing two major transactivating systems responsible for cellu-
lar response to hypoxia (Fig. 10). Noxa is categorized into
BH3-only members of Bcl-2 family proteins (17). Re-
cently, it has been proposed that BNip3, another member
of the proapoptotic BH3-only protein, is a target molecule
of HIF-1  in response to hypoxia (15). Although both
BNip3 and Noxa are BH3-only Bcl-2 proteins that re-
spond to hypoxia, it seems like that Noxa functions differ-
ently from BNip3. First, Noxa responds to hypoxia in early
stage (Fig. 1), whereas BNip3 accumulates in cells after ex-
posure to prolonged hypoxia (15). This suggests that Noxa
may participate in the early stage of ischemic damage. This
finding has potential clinical relevance for selection of tar-
gets in ischemic disorders at the early stage. Second, we and
others reported that the ability of BNip3 to facilitate cell
death depends on the transmembrane domain, but not on
the BH3 domain (18, 19). However, the BH3 domain is
crucial for cell death by Noxa (17), suggesting different cell
death pathways. And third, as discussed below, Noxa facili-
tates apoptosis through an ROS-dependent pathway (Fig.
Figure 9. Protection of brain from
ischemia by suppression of Noxa ex-
pression. SE or AS oligonucleotides
(2  g in 1  l) were injected into the
lateral ventricle 4 h before MCA occlu-
sion for 2 h. Brain was reperfused for
14 h, removed, and then cut into eight
coronal slices. (A) Representative sec-
tion stained with triphenyl tetrazolium
chloride (TTC). (B) Western blot
analysis of Noxa from the corresponding
slices of rat brain. (C) Infarction volume
was calculated after measuring the
infarct areas on coronal brain sections
as described in Materials and Methods.
The infarction volume of the control
animal (SE) was 154.24   28.38 mm3,
whereas that of the experimental
group (AS) was reduced to 48.86  
13.46 mm3 (*, P   0.05).
Figure 8. Expression of Noxa in ischemic rat brain from MCAO
model. Brain was infarcted with MCA occlusion for 2 h, reperfused for
14 h, and then removed. Sections from infarcted or contralateral brain
were (A) in situ hybridized with FITC-labeled cRNA probe (inset at
high magnification) and (B) immunostained with anti-Noxa antibody or
TUNEL stained. Fast Red substrate solution was used for chromagen in
in situ hybridization and TUNEL method. DAB was used for immuno-
staining. Original magnifications are shown in each panel.Noxa Mediates Hypoxic Injury 122
6), whereas BNip3 does so through an ROS-independent
pathway (unpublished data). Based on functional differ-
ences between Noxa and BNip3, our data presented here
categorize Noxa as a new member of the BH3-only pro-
teins that responds to hypoxia. It also suggests the possibil-
ity that BH3-only proteins might be the major downstream
effectors of HIF-1  in hypoxic cell death.
It is well known that hypoxia increases cellular ROS
generation, probably from mitochondrial electron transport
complexes (35). Once generated, ROS induces membrane
peroxidation, leading to destabilization of the mitochon-
drial and/or other cellular membranes. Also, it might be re-
quired to create a redox environment that facilitates the
functions of other proapoptotic proteins such as Bax and
BNip3 (36). Our data clearly show that Noxa induces cell
death by production of ROS, leading to cytochrome c re-
lease and caspase activation because (a) antioxidant NAC
inhibited cytochrome c release in Noxa-transfected cells
(Fig. 7 C) and (b) suppression of endogenous Noxa expres-
sion by AS significantly reduced cytochrome c release in
cells exposed to hypoxia (Fig. 7 D). However, it is not
clear whether Noxa-induced ROS initiates a cytochrome
c–dependent apoptotic machinery. Nevertheless, our data
provide clear evidence that ROS is crucial for Noxa-
induced cell death.
Our results from cell death assay and MCAO animal
model using AS oligonucleotide strongly suggest that Noxa
mediates hypoxic cell death and that Noxa is a candidate
target molecule of ischemia therapy in the acute stage. Hy-
poxia participates in numerous pathological processes such
as ischemic stroke, myocardial infarction, and chronic de-
generative disorders. Thus, hypoxia-induced cell death
genes are important targets for the development of drugs or
other treatment modalities. Overall, data presented here led
us to conclude that Noxa is an HIF-1 –induced proapop-
totic gene that mediates hypoxic cell death by generation of
ROS. It will be interesting to study the potential biological
significance of Noxa in transgenic and knockout mice.
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